Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 4,836	$ 8,501
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Investment related (gains) losses on sale of investments and other assets	486	(710)
Net deferred policy acquisition cost	(9,309)	(10,563)
Amortization of cost of insurance acquired	177	324
Depreciation	343	291
Amortization of premiums and discounts on investments	2,379	2,516
Stock-based compensation	1,797	640
Deferred federal income tax expense (benefit)	(375)	(944)
Change in:
Accrued investment income	23	(229)
Reinsurance recoverable	(2,447)	(1,226)
Due premiums	986	318
Future policy benefit reserves	(6,335)	(36)
Other policyholders' liabilities	14,670	12,942
Federal income tax receivable	(995)	543
Commissions payable and other liabilities	(1,417)	1,147
Other, net	(601)	(2,138)
Net cash provided by operating activities	4,218	11,376
Cash flows from investing activities:
Purchases of fixed maturity securities, available-for-sale	(34,375)	(35,650)
Sales of fixed maturity securities, available-for-sale	14,569	4,659
Maturities and calls of fixed maturity securities, available-for-sale	14,723	27,197
Principal payments on mortgage loans	4	5
Change in policy loans	1,568	1,897
Sales of other long-term investments	2,031	130
Purchases of other long-term investments	(4,872)	(8,250)
Purchase of property and equipment	(283)	(189)
Net cash used in investing activities	(6,635)	(10,201)
Cash flows from financing activities:
Annuity deposits	4,434	3,222
Annuity withdrawals	(8,345)	(5,017)
Other share repurchases	(272)	(33)
Net cash used in financing activities	(4,183)	(1,828)
Net increase (decrease) in cash and cash equivalents	(6,600)	(653)
Cash and cash equivalents at beginning of year	29,271	26,997
Cash and cash equivalents at end of period	$ 22,671	$ 26,344